Testing the effectiveness of antiemetic guidelines: results of a prospective registry by the CINV Study Group of Japan
| LEADER | caa a22 4500 | ||
|---|---|---|---|
| 001 | 605491615 | ||
| 003 | CHVBK | ||
| 005 | 20210128100511.0 | ||
| 007 | cr unu---uuuuu | ||
| 008 | 210128e20151001xx s 000 0 eng | ||
| 024 | 7 | 0 | |a 10.1007/s10147-015-0786-7 |2 doi |
| 035 | |a (NATIONALLICENCE)springer-10.1007/s10147-015-0786-7 | ||
| 245 | 0 | 0 | |a Testing the effectiveness of antiemetic guidelines: results of a prospective registry by the CINV Study Group of Japan |h [Elektronische Daten] |c [Kazuo Tamura, Keisuke Aiba, Toshiaki Saeki, Yoichi Nakanishi, Toshiharu Kamura, Hideo Baba, Kazuhiro Yoshida, Nobuyuki Yamamoto, Yuko Kitagawa, Yoshihiko Maehara, Mototsugu Shimokawa, Koichi Hirata, Masaki Kitajima] |
| 520 | 3 | |a Background: Many cancer patients suffer from the common side effect of chemotherapy-induced nausea and vomiting (CINV). Guidelines recommend a combination of two prophylactic antiemetics for moderately emetogenic chemotherapy (MEC) and three for highly emetogenic chemotherapy (HEC) and certain MEC regimens. Methods: This multicenter, prospective, observational study analyzed data for 1,910 patients in Japan scheduled for MEC or HEC. Use of antiemetic prophylaxis in relation to type of chemotherapy, incidences of and risk factors for nausea, vomiting, and acute versus delayed CINV, and estimated incidence of CINV by staff were analyzed using Fisher's exact test and multivariate logistic regression. The patients recorded the incidence of CINV and severity of nausea by visual analogue scales daily for 7days after receiving chemotherapy. Results: A total of 240 (20.1%) HEC and 476 MEC patients (66.6%) received 2 antiemetics, compared with 883 (73.9%) and 200 (28.0%), respectively, who received 3 antiemetics. Approximately 74% of HEC and 95% of MEC patients received antiemetic therapy in compliance with guidelines. Acute nausea and vomiting were well controlled, but high incidences of delayed nausea occurred in both HEC and MEC patients. Delayed vomiting (p<0.0001) was significantly less frequent in patients receiving three compared with 2 antiemetics. Female sex was a major risk factor for CINV. Medical staff tended to overestimate the incidence of CINV. Among HEC regimens, the incidence of CINV and the degree of nausea on day 1 of anthracycline-cyclophosphamide combination therapy were higher than with a cisplatin-based regimen. Conclusions: Adherence to antiemetic guidelines effectively controls vomiting but is less effective against delayed nausea in HEC and MEC patients. Identification of individual risk factors, such as female sex, will assist in the development of personalized treatments for CINV. More intensive antiemetic therapy or a different modality of prophylaxis should be considered for the control of acute CINV in an anthracycline-cyclophosphamide regimen. | |
| 540 | |a Japan Society of Clinical Oncology, 2015 | ||
| 690 | 7 | |a Cancer chemotherapy |2 nationallicence | |
| 690 | 7 | |a Antiemetics |2 nationallicence | |
| 690 | 7 | |a Guidelines |2 nationallicence | |
| 690 | 7 | |a Nausea |2 nationallicence | |
| 690 | 7 | |a Vomiting |2 nationallicence | |
| 700 | 1 | |a Tamura |D Kazuo |u Division of Medical Oncology, Hematology and Infectious Diseases, Department of Medicine, School of Medicine, Fukuoka University, 7-45-1, Nanakuma, Jonan-ku, 814-0180, Fukuoka, Fukuoko, Japan |4 aut | |
| 700 | 1 | |a Aiba |D Keisuke |u Division of Clinical Oncology/Hematology, Department of Internal Medicine, The Jikei University School of Medicine, 3-25-8, Nishi-shimbashi, Minato-ku, 105-8461, Tokyo, Japan |4 aut | |
| 700 | 1 | |a Saeki |D Toshiaki |u Breast Oncology Service, Saitama Medical University International Medical Center, 1397-1, Yamane, 350-1298, Hidaka, Saitama, Japan |4 aut | |
| 700 | 1 | |a Nakanishi |D Yoichi |u Research Institute for Diseases of the Chest, Kyushu University, 3-1-1, Maidashi, Higashi-ku, 812-8582, Fukuoka, Fukuoka, Japan |4 aut | |
| 700 | 1 | |a Kamura |D Toshiharu |u Department of Obstetrics and Gynecology, Kurume University School of Medicine, 67, Asahimachi, 830-0011, Kurume, Fukuoka, Japan |4 aut | |
| 700 | 1 | |a Baba |D Hideo |u Department of Gastroenterological Surgery, Kumamoto University, 1-1-1, Honjomachi, Chuo-ku, 860-0811, Kumamoto, Kumamoto, Japan |4 aut | |
| 700 | 1 | |a Yoshida |D Kazuhiro |u Department of Surgical Oncology, Gifu University, 1-1 Yanagito, 501-1194, Gifu, Gifu, Japan |4 aut | |
| 700 | 1 | |a Yamamoto |D Nobuyuki |u Division of Thoracic Oncology, Shizuoka Cancer Center, 1007, Nagaizumicho, Sunto-gun, 411-0934, Shizuoka, Japan |4 aut | |
| 700 | 1 | |a Kitagawa |D Yuko |u Department of Surgery, School of Medicine, Keio University, 35, Shinanomachi, Shinjuku-ku, 160-0016, Tokyo, Japan |4 aut | |
| 700 | 1 | |a Maehara |D Yoshihiko |u Department of Surgery and Science, Kyushu University, 3-1-1, Maidashi, Higashi-ku, 812-8582, Fukuoka, Fukuoka, Japan |4 aut | |
| 700 | 1 | |a Shimokawa |D Mototsugu |u Department of Cancer Information Research, National Hospital Organization Kyushu Cancer Center, 3-1-1, Notame, Minami-ku, 811-1395, Fukuoka, Fukuoka, Japan |4 aut | |
| 700 | 1 | |a Hirata |D Koichi |u Department of Surgery, Surgical Oncology and Science, Sapporo Medical University, S1 W17, Chuo-ku, 060-8556, Sapporo, Hokkaido, Japan |4 aut | |
| 700 | 1 | |a Kitajima |D Masaki |u International University of Health and Welfare, 2600-1 Kitakanemaru, 324-8501, Ohtawara, Tochigi, Japan |4 aut | |
| 773 | 0 | |t International Journal of Clinical Oncology |d Springer Japan |g 20/5(2015-10-01), 855-865 |x 1341-9625 |q 20:5<855 |1 2015 |2 20 |o 10147 | |
| 856 | 4 | 0 | |u https://doi.org/10.1007/s10147-015-0786-7 |q text/html |z Onlinezugriff via DOI |
| 898 | |a BK010053 |b XK010053 |c XK010000 | ||
| 900 | 7 | |a Metadata rights reserved |b Springer special CC-BY-NC licence |2 nationallicence | |
| 908 | |D 1 |a research-article |2 jats | ||
| 949 | |B NATIONALLICENCE |F NATIONALLICENCE |b NL-springer | ||
| 950 | |B NATIONALLICENCE |P 856 |E 40 |u https://doi.org/10.1007/s10147-015-0786-7 |q text/html |z Onlinezugriff via DOI | ||
| 950 | |B NATIONALLICENCE |P 700 |E 1- |a Tamura |D Kazuo |u Division of Medical Oncology, Hematology and Infectious Diseases, Department of Medicine, School of Medicine, Fukuoka University, 7-45-1, Nanakuma, Jonan-ku, 814-0180, Fukuoka, Fukuoko, Japan |4 aut | ||
| 950 | |B NATIONALLICENCE |P 700 |E 1- |a Aiba |D Keisuke |u Division of Clinical Oncology/Hematology, Department of Internal Medicine, The Jikei University School of Medicine, 3-25-8, Nishi-shimbashi, Minato-ku, 105-8461, Tokyo, Japan |4 aut | ||
| 950 | |B NATIONALLICENCE |P 700 |E 1- |a Saeki |D Toshiaki |u Breast Oncology Service, Saitama Medical University International Medical Center, 1397-1, Yamane, 350-1298, Hidaka, Saitama, Japan |4 aut | ||
| 950 | |B NATIONALLICENCE |P 700 |E 1- |a Nakanishi |D Yoichi |u Research Institute for Diseases of the Chest, Kyushu University, 3-1-1, Maidashi, Higashi-ku, 812-8582, Fukuoka, Fukuoka, Japan |4 aut | ||
| 950 | |B NATIONALLICENCE |P 700 |E 1- |a Kamura |D Toshiharu |u Department of Obstetrics and Gynecology, Kurume University School of Medicine, 67, Asahimachi, 830-0011, Kurume, Fukuoka, Japan |4 aut | ||
| 950 | |B NATIONALLICENCE |P 700 |E 1- |a Baba |D Hideo |u Department of Gastroenterological Surgery, Kumamoto University, 1-1-1, Honjomachi, Chuo-ku, 860-0811, Kumamoto, Kumamoto, Japan |4 aut | ||
| 950 | |B NATIONALLICENCE |P 700 |E 1- |a Yoshida |D Kazuhiro |u Department of Surgical Oncology, Gifu University, 1-1 Yanagito, 501-1194, Gifu, Gifu, Japan |4 aut | ||
| 950 | |B NATIONALLICENCE |P 700 |E 1- |a Yamamoto |D Nobuyuki |u Division of Thoracic Oncology, Shizuoka Cancer Center, 1007, Nagaizumicho, Sunto-gun, 411-0934, Shizuoka, Japan |4 aut | ||
| 950 | |B NATIONALLICENCE |P 700 |E 1- |a Kitagawa |D Yuko |u Department of Surgery, School of Medicine, Keio University, 35, Shinanomachi, Shinjuku-ku, 160-0016, Tokyo, Japan |4 aut | ||
| 950 | |B NATIONALLICENCE |P 700 |E 1- |a Maehara |D Yoshihiko |u Department of Surgery and Science, Kyushu University, 3-1-1, Maidashi, Higashi-ku, 812-8582, Fukuoka, Fukuoka, Japan |4 aut | ||
| 950 | |B NATIONALLICENCE |P 700 |E 1- |a Shimokawa |D Mototsugu |u Department of Cancer Information Research, National Hospital Organization Kyushu Cancer Center, 3-1-1, Notame, Minami-ku, 811-1395, Fukuoka, Fukuoka, Japan |4 aut | ||
| 950 | |B NATIONALLICENCE |P 700 |E 1- |a Hirata |D Koichi |u Department of Surgery, Surgical Oncology and Science, Sapporo Medical University, S1 W17, Chuo-ku, 060-8556, Sapporo, Hokkaido, Japan |4 aut | ||
| 950 | |B NATIONALLICENCE |P 700 |E 1- |a Kitajima |D Masaki |u International University of Health and Welfare, 2600-1 Kitakanemaru, 324-8501, Ohtawara, Tochigi, Japan |4 aut | ||
| 950 | |B NATIONALLICENCE |P 773 |E 0- |t International Journal of Clinical Oncology |d Springer Japan |g 20/5(2015-10-01), 855-865 |x 1341-9625 |q 20:5<855 |1 2015 |2 20 |o 10147 | ||